Sato Takeo, Kokuba Yukihito, Ozawa Heita, Hatate Kazuhiko, Nakamura Takatoshi, Onosato Wataru, Ihara Atsushi, Watanabe Masahiko
Dept. of Surgery, Kitasato University School of Medicine.
Gan To Kagaku Ryoho. 2006 Dec;33 Suppl 2:257-9.
We report the outpatient chemotherapy of an advanced or metastatic colorectal cancer. From April 2005 to May 2006, 50 patients were treated with FOLFIRI or FOLFOX in our hospital. Forty five patients (90%) had an intravenous catheter and a port for the chemotherapy, 23 patients (46%) were treated at the outpatient booths. We used the clinical pathway in chemotherapy for patients and co-medical roles. We were not experiencing emergency admission of side effects. Outpatient chemotherapy utilizing FOLFIRI or FOLFOX for advanced or metastatic colorectal cancer can be enforced safely by using the clinical pathway.
我们报告了晚期或转移性结直肠癌的门诊化疗情况。2005年4月至2006年5月，我院50例患者接受了FOLFIRI或FOLFOX化疗。45例患者（90%）有静脉导管和化疗用的端口，23例患者（46%）在门诊治疗。我们在患者化疗及共同医疗角色中采用了临床路径。我们未遇到副作用导致的紧急入院情况。通过使用临床路径，利用FOLFIRI或FOLFOX进行晚期或转移性结直肠癌的门诊化疗可以安全实施。
